SCHEMBL187417

SCHEMBL187417

[Na+].[Na+].[O-]B([O-])Oc1ccccc1

nearest known ligand 0.43

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 known ✓ P22748 1/20 0.39
CA1 known ✓ P00915 2/20 0.34
CA2 known ✓ P00918 2/20 0.34
LTA4H P09960 3/20 0.43
TSHR P16473 1/20 0.43
KCNA3 P22001 1/20 0.36
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
NR1H2 P55055 1/20 0.33
BAX Q07812 1/20 0.33
MAOA P21397 1/20 0.33
SOS1 Q07889 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RECQL P46063 1/20 0.32
CA9 Q16790 1/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29118344 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29232696 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL31538469 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Lithium Ion SCHEMBL188290 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Lithium Ion SCHEMBL28887480 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL28459811 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL414391 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL188076 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Potassium Ion SCHEMBL187986 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29213652 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119842323-A CMP composition for obtaining high-quality SiC monocrystal substrate surface and preparation method thereof 郑州磨料磨具磨削研究所有限公司 2025-04-18 CN claimed
CN-118370852-A Painless drainage robot and preparation method and application thereof 电子科技大学 2024-07-23 CN claimed
CN-118184589-A Preparation process of deoxyfructosazine and application of deoxyfructosazine and fructosazine in cosmetics 大连理工大学 2024-06-14 CN claimed
CN-115301221-B Boron-doped carbon-based catalytic accelerator and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2024-05-31 CN claimed
EP-2185493-B1 PROCESS OF REFINING C6-16 ALIPHATIC DIOLS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-09-28 EP claimed
US-8143457-B2 Process of refining C6-C16 aliphatic diols DOW GLOBAL TECHNOLOGIES LLC 2012-03-27 US claimed
US-20100267997-A1 PROCESS OF REFINING C6-16 ALIPHATIC DIOLS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2010-10-21 US claimed
EP-2185493-A1 PROCESS OF REFINING C6-16 ALIPHATIC DIOLS Dow Global Technologies Inc. (US) 2010-05-19 EP claimed
WO-2009017936-A1 PROCESS OF REFINING C6-16 ALIPHATIC DIOLS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-02-05 WO claimed
EP-0020974-B1 ELECTROCHROMIC PRINTING INK DISSOLVED IN WATER AND METHOD FOR PRINTING WITH THIS PRINTING INK International Business Machines Corporation (US) 1984-02-08 EP claimed
US-4211616-A Electrochromic printing system INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1980-07-08 US claimed
EP-4741371-A1 METHOD FOR PRODUCING DICARBOXYLIC ACID COMPOUND AND METHOD FOR PRODUCING RECYCLED RESINS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-05-13 EP disclosed
CN-122010983-A Compound, material for organic electroluminescent element, and electronic device 出光兴产株式会社 2026-05-12 CN disclosed
US-12617902-B2 Composition and siloxane-based thermoplastic resin using same, and methods for producing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-05-05 US disclosed
US-20260117008-A1 Thermoplastic Resin, Preparation Method Therefor, and Use Thereof TOPOLEFIN TECHNOLOGY (QUZHOU) CO., LTD. (CN) 2026-04-30 US disclosed
EP-0508775-A2 Method of producing copolymerized polycarbonates GE PLASTICS JAPAN LIMITED (JP) 1992-10-14 EP disclosed
EP-0508774-A2 Copolymerized polycarbonates GE PLASTICS JAPAN LIMITED (JP) 1992-10-14 EP disclosed
EP-0020974-B1 ELECTROCHROMIC PRINTING INK DISSOLVED IN WATER AND METHOD FOR PRINTING WITH THIS PRINTING INK International Business Machines Corporation (US) 1984-02-08 EP disclosed
EP-0020974-A1 Electrochromic printing ink dissolved in water and method for printing with this printing ink International Business Machines Corporation (US) 1981-01-07 EP disclosed
US-4211616-A Electrochromic printing system INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1980-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117008-A1 Thermoplastic Resin, Preparation Method Therefor, and Use Thereof CYP51A1, FDFT1, CYP46A1 CA4 2271/4885CA1 1248/4885CA2 2460/4885
US-12617902-B2 Composition and siloxane-based thermoplastic resin using same, and methods for producing same OR10J3, ASH2L, CCRL2 CA4 2486/4885CA1 1489/4885CA2 2771/4885
US-20100267997-A1 PROCESS OF REFINING C6-16 ALIPHATIC DIOLS ADH1C, ADH1A, AKR7A2 CA4 894/4885CA1 691/4885CA2 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.